Etoposide
NDC 0378-3266, etoposide, capsule, from Mylan Pharmaceuticals Inc..
- Product NDC
- 0378-3266
- Status
- Listed
- Labeler
- Mylan Pharmaceuticals Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA075635
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0378-3266 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ETOPOSIDE50 mg/1
Pharmacologic classes
Topoisomerase Inhibitor [EPC]; Topoisomerase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0378-3266-94 | 00378326694 | 20 CAPSULE in 1 CARTON (0378-3266-94) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/508a418e-985f-4208-9324-2230655bb5c2Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=0378-3266
Use it
Look up 0378-3266 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0378-3266 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0378-3266. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.